Skip to content

AARD AARD Change in Lease Liabilities

Change in Lease Liabilities at other companies

Viking Therapeutics logo
Viking TherapeuticsVKTX
-$139K-7.8%
Arvinas logo
ArvinasARVN
-$400K+20.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$547K-260%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's change in lease liabilities?
AARD (AARD) reported change in lease liabilities of -$105K in Q1 2026.
How has AARD's change in lease liabilities changed year-over-year?
AARD's change in lease liabilities decreased by 98.1% year-over-year, from -$53K to -$105K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.